|
| Author/year | Type of devices used | Antithrombotic used after device implant | Duration of anticoagulation | Duration of antiplatelet |
|
| Ajmal/2020 | Watchman | VKA 11
DOACs 5 | 1.5 | DAPT 4.5 mo
ASA lifelong |
|
| Fayos-vidal/2020 | Amplatzer Amulet 7
Amplatzer Cardiac Plug 2 | ASA or clopidogrel 5
Not reported 4 | N/A | 6 months single agent |
|
| Pouru/2020 | Watchman 2
Amplatzer Amulet 60
Amplatzer Cardiac Plug 42 | VKA 1
DOAC 10
LMWH 23
ASA 72el 4
ASA + clopidogrel 19
ASA + dipyridamole 2
ASA + Plavix + dipyridamole 2 | ≤14 days in 17 pts (50%)
≤1 month in 31 pts (91%) | Clopidogrel ≤ 1 month in 21 pts
ASA for ≤6 months in 62 pts
After 6 months ASA 28, ASA + dipyridamole 4 |
|
| Hucker/2019 | Watchman | VKA 18
DOAC 32
OAC + ASA 27 (out of 50 on OAC)
DAPT 12 | 1.5 | DAPT 4.5 mo
ASA lifelong |
|
| Hutt/2019 | Watchman | VKA 21 (55%)
DOAC 17 (45%) | 1.5 | DAPT for 4.5 months 15
ASA lifelong |
|
| Nielsen-Kudsk/2017 | Amplatzer Cardiac Plug and Amplatzer Amulet | Clopidogrel 64 (62.1%)
ASA 36 (31.1%)
None 7 (6.8%) | N/A | 6 months |
|
| Tzikas/2017 | Amplatzer Amulet | DOAC 3, VKA 14
Clopidogrel 10, ASA + LMWH 6, ASA + DOAC 1
ASA + VKA 9, DAPT 22,
ASA84, triple therapy 1, LMWH 24, no treatment 24 | Not reported | Not reported |
|
| Renou/2017 | Watchman and Amplatzer Cardiac Plug used; no numbers given | DAPT 1
ASA 43 | N/A | DAPT 6 months
ASA lifelong |
|
| Martínez-Domeño/2017 | 2 Amplatzer Amulet
7 Amplatzer Cardiac Plug | 5 Plavix, 4 aspirin | N/A | Not reported |
|
| Cru-Gonzal/2017 | Watchman 24,
Amplatzer Amulet 21
Amlatzer Cardiac Plug 2 | DAPT 38
LMWH 2
Clopidogrel 1
ASA 4 | 1.5 | 1.5 |
|
| Fahmy/2016 | Watchman 9
Amlatzer Amulet 5
Amlatzer Cardiac Plug 12 | DAPT 24
Clopidogrel 1
ASA 1 | N/A | 12 DAPT 1 mo
11 DAPT 3 mo
1 DAPT 6 mo |
|
| Horstman/2014 | Amplatzer Cardiac Plug | VKA 1
DAPT 3 mo | 3 mo | DAPT 19
ASA lifelong |
|
